David M. Demski is the former CEO of Globus Medical, a company known for its innovative approach in the medical device industry. Appointed in 2017, he succeeded David C. Paul, who transitioned to Executive Chairman. Demski has a rich history...

David M. Demski is the former CEO of Globus Medical, a company known for its innovative approach in the medical device industry. Appointed in 2017, he succeeded David C. Paul, who transitioned to Executive Chairman. Demski has a rich history with the company, having been a director since its founding in 2003. Before becoming CEO, he served in various roles including President of Emerging Technologies and Chief Operating Officer. His expertise in business and operations is backed by a strong educational background with a B.S. from the University of Michigan and an MBA from Stanford. Demski has an impressive career that includes stints as an executive in venture capital and consulting, and he even managed international distribution for Domino's Pizza during its growth phase in the late 1980s. Under his leadership, Globus Medical focused on performance-based compensation, aligning executive pay with company success. He had significant stock option grants during his tenure, reflecting the company’s growth. Demski stepped down in 2022, paving the way for new leadership while leaving a legacy of innovation and strategic planning at Globus.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Globus Medical CEOs

G

David M. Demski

Ex-CEO of Globus Medical

Education

B.S. in Business Administration from the University of Michigan, M.B.A. from Stanford Graduate School of Business

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

January 1, 1964 - 61 years ago

CEO of Globus Medical for

4 years 7 months (Aug 2017 - Apr 2022)

Previous Experience

President and Chief Operating Officer from August 2008 until September 2015, Chief Financial Officer from 2003 until August 2008.

Rivals

Competitors/colleagues of David M. Demski

Holdings

See how much did David M. Demski make over time.

During his time at Globus Medical, David Demski saw fluctuations in his stock holdings. At one point in late 2019, his holdings valued around $10.44 million, spiking to over $14 million by the end of 2020. However, these values changed...

During his time at Globus Medical, David Demski saw fluctuations in his stock holdings. At one point in late 2019, his holdings valued around $10.44 million, spiking to over $14 million by the end of 2020. However, these values changed notably, dropping significantly to around $2.30 million by January 2023. His stock options were substantial, particularly with grants of 300,000 shares designed to vest over four years, underscoring the company's growth trajectory during his leadership. After 2020, though, his holdings steadily decreased, indicating challenges in retaining stock value or acquiring new shares, reflecting broader market trends and company performance. Overall, Demski's financial ties to Globus are a notable part of his career story.

Mar 17, 2025

G

shares

GMED @ $72.14

Total Stock Sold

$98.61M

GMED

$98.61M

2,169,547 GMED shares

What if they kept their stock?

If David M. Demski didn't sell their stock, today they would have:
Extra GMED2,169,547 shares worth $114.42M.
This is 16.04% and $15.82M more than what they got when they sold the stock.

Charitable Transactions

GMED

90,000 shares

GMED

Recent Charitable Transactions

GMED

40,000 shares

GMED

Aug 22, 2013

Charity

GMED

50,000 shares

GMED

Dec 27, 2012

Charity

Insider Trading

See recent insider trades of David M. Demski.

GMED

$19.00M

GMED at $71.55/share

Apr 23, 2021

Sale

GMED

$13.94M

GMED at $64.20/share

Dec 16, 2020

Sale

GMED

$18.55M

GMED at $56.23/share

Aug 6, 2020

Sale

GMED

$18.55M

GMED at $56.23/share

Aug 6, 2020

Sale

GMED

$7.60M

GMED at $51.00/share

Apr 18, 2018

Sale

GMED

$2.60M

GMED at $51.00/share

Apr 12, 2018

Sale

GMED

$845.26K

GMED at $26.00/share

Feb 26, 2015

Sale

GMED

$7.11M

GMED at $26.22/share

Mar 6, 2014

Sale

GMED

$1.99M

GMED at $20.51/share

Jan 15, 2014

Sale

GMED

$64.54K

GMED at $20.25/share

Dec 31, 2013

Sale

Compensation History

See how much did David M. Demski make over time.

David Demski's compensation during his time as CEO at Globus Medical was built on a performance-driven model. In 2022, he earned a total of $4.74 million, mainly from a base salary of $513,446. His bonus structure tied directly to achieving revenue goals, focusing on hitting targets like $1,050 million in revenue for that year. Notably, he wasn’t awarded any eye-catching stock options but was granted significant options worth $3 million in stock in the previous years. This structure aimed to motivate executive performance aligning with shareholder interests, a common trend in executive compensation. The philosophy behind his pay designed to attract skilled leadership in the competitive medical technology market shows the seriousness of the company’s approach to executive roles.

Year

2022

Total Compensation

$564.40K

Salary

$513.45K

Board Justification

The compensation philosophy is designed to attract and retain talented leaders, aligning executive compensation with company performance and shareholder interests.

Bonus

$30.04K

Board Justification

The bonus is based on individual and company performance metrics, specifically tied to revenue goals for 2022.

Other

$20.91K

Board Justification

Other compensation includes benefits such as health insurance, retirement contributions, and car allowance.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards vested in 2022 as the focus was on performance-based compensation.

Performance Metrics

The primary performance metric for 2022 was revenue achievement against a target of $1,050 million.

Other Globus Medical CEOs

Here are other CEOs of Globus Medical

David C. Paul

Founder and Ex-CEO of Globus Medical

January 2003 - August 2017

Daniel T. Scavilla

CEO of Globus Medical

April 2022 - Present